Pioglitazone is an oral anti-hyperglycemic agent. It is used for the treatment of diabetes
mellitus type 2. It selectively stimulates nuclear receptor peroxisome proliferator-activated …

Pioglitazone is a thiazolidinedione antidiabetic with actions similar to those of rosiglitazone.
It is used in the management of type 2 diabetes mellitus and is prepared by reducing 5-[4-[2 …

Pioglitazone Hydrochloride (PG) is an insulin‐sensitizing drug and is indicated for the
treatment of type II diabetes. In this study, newly molecularly imprinted electrochemical …

A novel, high throughput and sensitive LC-MS/MS assay method was developed and fully
validated for quantitative determination of pioglitazone, its hydroxyl metabolite and alogliptin …

Based on the flow injection analysis (FIA) and the gold nanoparticles (AuNPs) optical probe,
a rapid and precise automation method was developed and was used for the determination …

In this work two well known oral hypoglycemic drugs that are administered in combination
for patients with type‐II diabetes were simultaneously determined. Several …

A systematic and critical review was conducted on bioanalytical methods validated to
quantify combinations of antidiabetic agents in human blood. The aim of this article was to …

Pioglitazone is a prescription drug of thiazolidinedione group with hypoglycemic action.
Based on the computiational studies, pioglitazone-tetraphenyl borate was selected as a …

The review presents analytical methods for determination of new oral drugs for the treatment
of type 2 diabetes mellitus (T2DM), focusing on peroxisome proliferator-activated receptor …

New simple accurate methods were developed and validated for simultaneous
determination of Metformin hydrochloride and Pioglitazone hydrochloride in presence of …